20 April 2004
Clinical course and treatment results of JMML in three children
Iwona Malinowska, Barbara Sikorska-Fic, Elżbieta Stasiak-ZającCase Rep Clin Pract Rev 2004; 5(null):217-221 :: ID: 12290
Abstract
Background: We report three cases of juvenile myelomonocytic leukemia in children. Juvenile myelomonocytic leukemia (JMML) is a rare myeloproliferative disorder of childhood, representing 1-2%
of all leukaemias, with characteristic clinical and laboratory findings.Case Report: Clinical symptoms at a time of diagnosis included fever, frequent viral infections, hepatosplenomegaly, lymph node enlargement and cutaneous xanthogranuloma. Hematological findings were characterized by thrombocytopenia, leukocytosis with an increase of mature and immature myeloid cells and monocytes in the absence of the Philadelphia chromosome. One patient had deletion in chromosome 7 and another increased HbF concentration. Different treatment strategies including low dose chemotherapy, intensive AML therapy and /orretinoids were employed to treat our patients with only transient regression of the disease. One patient underwent the allo-BMT procedure which was complicated with early relapse. Intensive chemotherapy was complicated with severe toxicities. Among our patients the younger 3- month- old, had the longer survival of 2 years. Two other patients died 7,5 and 12 months from diagnosis.Conclusions: The treatment of JMML continues to generate controversy. Regardless of the type of treatment regimen, chemotherapy never results in complete remission. Also, neither splenectomy nor radiotherapy is of value in the treatment of JMML. Currently, bone marrow transplantation (BMT) is the therapy of choice that clearly improves outcome in the clinical management of JMML, but is associated with high transplant related mortality (TRM) and a high relapse rate.
Keywords: JMML, BMT, myeloproliferative disorders
44
In Press
12 Mar 2024 : Case report
Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeu...Am J Case Rep In Press; DOI: 10.12659/AJCR.943244
13 Mar 2024 : Case report
Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diag...Am J Case Rep In Press; DOI: 10.12659/AJCR.943275
13 Mar 2024 : Case report
Unveiling the Temporal Aspect of MRI Tattoo Reactions: A Prospective Evaluation of a Newly-Acquired Tattoo ...Am J Case Rep In Press; DOI: 10.12659/AJCR.943411
13 Mar 2024 : Case report
Cardiac and Intramuscular Metastases Following Nephroureterectomy for Metachronous Urothelial CarcinomaAm J Case Rep In Press; DOI: 10.12659/AJCR.942864
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250